TỶ LỆ CÁC LOẠI THUỐC ĐƯỢC KÊ CHO BỆNH NHÂN SUY THẬN MẠN CÓ ĐÁI THÁO ĐƯỜNG ĐIỀU TRỊ NGOẠI TRÚ TẠI BỆNH VIỆN ĐA KHOA TỈNH LONG AN NĂM 2023

Abstract

Objective: Determine the rate of drugs prescribed for chronic kidney failure patients with diabetes treated as outpatients at Long An Provincial General Hospital in 2023. Subjects and methods: cross-sectional descriptive study. Conducted research on 360 medical records and 250 prescriptions of STD patients with diabetes treated as outpatients at the Department of Internal Medicine of Long An Provincial General Hospital from January 1, 2023 to December 31, 2023. Results: The most commonly used hypoglycemic drugs are biguanide (43.3%), insulin (40.8%), sulfonylurea (38.8%). The most commonly used drug groups are calcium channel blockers (41.2%), ARBs (32.2%), diuretics (27.5%), and ACEIs (26.4%). Antihypertensive drug combinations with ACEI/ARB account for a high proportion (56.9%), but the rate of use with ACEI/ARB is different in stages of chronic kidney failure. Most patients used statins (53.6%), of which atorvastatin was used the most (52.5%). The proportion of CKD patients with diabetes using drugs to treat anemia was 31.7% and the rate of using drugs to treat anemia increased with statistical significance according to CKD stage, from 0 0% in stage 1 to 62.5% in stage 4. Conclusion: Chronic kidney failure patients with diabetes treated as outpatients often use a combination of drugs such as hypoglycemia, hypotension, lowering blood fat, group of drugs to treat anemia.